A Study to Evaluate the Efficacy and Safety of SG001 in Combination With Nab-Paclitaxel in Patients With Advanced Triple-Negative Breast Cancer (TNBC)
Clinical trial NCT05068141 · UNKNOWN
Trial details
- NCT number
- NCT05068141
- Sponsor
- CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-10-01
- Primary completion
- 2022-10-01
- Enrollment
- 79
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.